Skip to content

Discontinued — last reported Q3 '22

Net margin at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
15.2%+1.0pp
Danaher logo
DanaherDHR
14.9%-0.9pp
Azenta logo
AzentaAZTA
-29.1%-80.7pp
LeMaitre Vascular logo
LeMaitre VascularLMAT
24.3%+4.4pp
TEC
Bio-TechneTECH
10.9%-6.7pp
CryoPort, Inc. logo
CryoPort, Inc.CYRX
39.2%+22.1pp

Other financials

Income statement

See full
Revenue$27.5M+24.7%
Gross profit$17.5M+18.2%
Operating income$27.0K+105%
Net income$1.2M+365%
EPS (diluted)$0.02

Balance sheet

See full
Cash & equivalents$22.8M-65.9%
Total debt$17.4M-35.6%
Total equity$372.2M+5.6%
Total assets$400.9M+1.5%

Cash flow

See full
Operating cash flow-$491.0K-128%
CapEx$167.0K-4.6%
Free cash flow-$658.0K-142%

Valuation

See full
Market cap$1.25B+23.8%
Enterprise value$1.24B+28.3%
P/S12.5×-0.4×

Profitability

See full
Gross margin66.9%
Operating margin-16.7%
FCF margin-15.9%+18.7pp

Returns & leverage

See full
Return on equity-14.5%-4.7pp
Debt / equity0.0×
Current ratio7.3×+2.6×

Where this comes from

Calculated from BioLife Solutions’s reported figures.

Based on trailing twelve months.

The official record: BioLife Solutions’s 10-Q, filed November 9, 2023, on SEC EDGAR. View the filing →

Ask your AI about BioLife Solutions's net margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is BioLife Solutions's net margin?
BioLife Solutions (BLFS) reported net margin of -68.7% in Q3 2022.
What does net margin mean?
Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.